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Abstract
Purpose of Review Physical activity is a fundamental part of lifestyle management in diabetes care. Although its benefits are very
well recognized in the general population and in people with type 2 diabetes, much less is known about the effects of exercise in
type 1 diabetes. In particular, exercise effects in relation to diabetic kidney disease (DKD) are understudied. Some uncertainties
about physical activity recommendations stem from the fact that strenuous exercise may worsen albuminuria immediately after
the activity. However, in middle-aged and older adults without diabetes, observational studies have suggested that physical
activity is associated with a decreased risk of rapid kidney function deterioration. In this review, we focus on the role of physical
activity in patients with DKD and type 1 diabetes.
Recent Findings Hereby, we present data that show that in individuals at risk of DKD orwith established DKD, regular moderate-
to-vigorous physical activity was associated with reduced incidence and progression of DKD, as well as reduced risk of
cardiovascular events and mortality.
Summary Therefore, regular moderate-to-vigorous exercise should become a central part of the management of individuals with
type 1 diabetes, in the absence of contraindications and accompanied with all needed educational support for optimal diabetes
management.
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Introduction
Patients living with diabetes are recommended to engage in
150 min of moderate-to-vigorous intensity aerobic activity per
week to realize benefits on metabolism, fitness, and well-
being [1]. Patients are also encouraged to avoid being seden-
tary for more than 2 consecutive days (Table 1). In addition,
resistance and flexibility exercises are recommended two to
three times per week [1]. Active adults with type 1 diabetes
achieve better blood pressure values and lipid profile and have
improved body composition, cardiorespiratory fitness, and
well-being compared with their inactive counterparts [4, 5].
Although individuals with regular physical activity have re-
duced daily insulin dose, its effect on glycemic control,
expressed by glycated hemoglobin A1c (HbA1c), is not
straightforward. The reasons why regular physical activity
may not translate directly into lower HbA1c values may be
increased calorie intake, decreased insulin dose, and a reduc-
tion in glycemic variability [6]. Of note, exercise does not only
decrease blood glucose concentration, but has also been pos-
tulated that the addition of brief intervals of high intensity,
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sprint-type exercise to aerobic exercise can minimize the risk
of hypoglycemia and even decrease the risk of late nocturnal
hypoglycemic episodes [7, 8].
Unfortunately, persons with type 1 diabetes less often
engage in physical activity compared with the general pop-
ulation [9], with a large percentage of individuals not
achieving the recommended minimum amount of
moderate-to-vigorous aerobic activity per week. In a recent
large cross-sectional study of 18,028 adults with type 1
diabetes from Austria and Germany, it was shown that less
than 20% of individuals manage to engage in aerobic ex-
ercise more than 2 times per week and only about 40% of
individuals perform structured exercise [4]. There were
many potential barriers to exercise identified (Table 2),
with the most important ones being fear of hypoglycemia,
loss of glycemic control, and inadequate knowledge of
diabetes management around and during exercise [9].
Epidemiological data suggest that around 20% of indi-
viduals with type 1 diabetes will develop end-stage renal
disease (ESRD) during their lifetime, although the inci-
dence of ESRD is decreasing [11]. The presence of dia-
betic kidney disease (DKD) is an important risk factor for
ESRD and also of cardiovascular or non-cardiovascular
mortality, even in patients with an estimated glomerular
filtration rate (eGFR) above 60 ml/min/1.73 m2 [12–14].
In this review, the possible mechanisms promoting bene-
ficial effects of physical activity on DKD will be
summarized. Second, we briefly review data on the role
of exercise in non-diabetic kidney disease. Finally, we
will describe the basic recommendations for applying
the existing knowledge on the effects of physical activity
on DKD development and progression in type 1 diabetes
into clinical practice.
Mechanisms of Beneficial Effects of Physical
Activity on Chronic Kidney Disease
Even a short period of structured physical activity triggers
many changes at multiple tissue levels that could contrib-
ute to its beneficial effects in the prevention of initiation or
progression of kidney disease (Fig. 1).
Physical Activity Improves Endothelial Function
Physical activity modulates nitric oxide (NO) synthesis by
increasing NO precursor L-arginine bioavailability and ac-
tivity of endothelial NO synthase [15]. In addition, it re-
duces NO degradation by reducing reactive oxygen species
(ROS) [15]. Nitric oxide is known as one of the most im-
portant paracrine modulators of renal function, effecting
renal autoregulation, glomerular filtration, renin secretion,
and salt excretion [16]. Deficiency in nitric oxide has been
implicated in renal disease deterioration, including
Table 1 Recommended physical
activity in patients with diabetes
[1, 2]
Type Duration/
week
Special notice
Aerobic 150 min Moderate-to-vigorous intensity*, no more than 2 days without activity
Resistance 2–3
sessions
Sessions should be scheduled on non-consecutive days; sessions should include
8–10 exercises with completion of 1–3 sets of 10–15 repetitions using free
weights, resistance machines, resistance bands or performing exercise against
body weight
Flexibility 2–3
sessions
Especially recommended for older adults
*Moderate intensity can be defined as the intensity of 3-5,9 MET (metabolic equivalent) or exercise when your
breathing is faster but compatible with speaking full sentences; vigorous intensity can be defined as the intensity
of ≥ 6 MET or exercise when breathing is very hard and you cannot carry on a conversation comfortably [3]
Table 2 Perceived barriers to
physical activity summarized
according to Brazeau et al. [9] and
Clarke et al. [10]
Type 1 diabetes Chronic kidney disease
Fear of hypoglycemia Poor health
Fear of loss of glycemic control Fear of injury or aggravating their condition
Inadequate knowledge of diabetes management in relation to
exercise
Lack of guidance from their health
professional
Work schedule Lack of facilities
Low levels of fitness Lack of social support
Lack of social support
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worsening of glomerulosclerosis and tubulointerstitial in-
flammation with fibrosis [17].
Physical Activity Improves Insulin Sensitivity
Even a single bout of exercise, independent of weight loss, leads
to increased insulin sensitivity [18]. Namely, it facilitates non-
insulin-mediated glucose uptake into skeletal muscle and acti-
vates AMP-activated protein kinase (AMPK). This results in
the phosphorylation of the Rab-GTPase-activating protein
TBC1D1 (Tre-2/BUB2/cdc 1 domain family, member 1), in-
volved in regulation of intracellular membrane trafficking.
Phosphorylation inactivates TBC1D1 thereby enabling GTP to
react with Rab proteins on the GLUT4 vesicles, thus, increasing
GLUT4 vesicle translocation from cytosol to the cell membrane
and increasing glucose uptake into the cell [19]. In this way,
exercise increasesmuscle glucose uptake, independent of insulin.
In advanced kidney disease, insulin resistance was shown to be
mainly the result of the impaired muscle phosphatidylinositol 3-
kinase/Akt signaling contributing to its impaired anabolic re-
sponse, increased catabolism, and muscle wasting [20, 21].
Also, at earlier stages of kidney disease, insulin resistance leads
to hyperinsulinemia that activates the phosphatidylinositol-3-ki-
nase/protein kinase B (Akt) pathway. In endothelial cells, this
activation results in the reduction of Akt-dependent synthesis of
nitric oxide and in increased mitogen-activated protein kinase
(MAPK)-dependent vasoreactivity, contributing to microvascu-
lar damage [22]. However, even more interesting is the role of
insulin signaling at the level of the podocyte. Of note, podocytes
have been shown to be responsive to insulin for glucose uptake
and metabolism. In vitro models have demonstrated that
podocyte-specific insulin resistance leads to albuminuria, togeth-
er with thickened glomerular basement membrane and
glomerulosclerosis [23]. However, it is yet unknown whether
exercise-induced improvement in insulin sensitivity could trans-
late into improved podocyte insulin signaling.
Physical Activity Induces Changes in Adipose Tissue
and Adipocytokines
Visceral adipocytes have been shown to produce an array of
adipocytokines that could contribute to endothelial injury in
the kidney influencing progression to chronic kidney disease
(CKD), such as angiotensinogen, TNF-α, plasminogen acti-
vator inhibitor-1, resistin, ghrelin, and leptin [24]. Weight loss
protects against progression of CKD [25]. Moreover, altered
distribution of adipose tissue, and more specifically, loss of
visceral adiposity are associated with a decrease in reactive
oxygen species and inflammation that could result in im-
proved renal outcomes [26].
Physical Activity Reduces Inflammation
CKD is a chronic inflammatory state. Increased production
and decreased clearance of pro-inflammatory cytokines, oxi-
dative stress, and acidosis, as well as susceptibility to infec-
tions and intestinal dysbiosis, all contribute to chronic inflam-
mation that is adversely associated with albuminuria and mea-
sures of kidney function [27, 28]. In addition, pro-
inflammatory molecules, such as TNF-α, are potent triggers
of osteoclast activation and contribute to the adverse effects on
the bone and skeletal muscle metabolism with resultant bone
resorption, sarcopenia and cachexia, and also vessel wall dis-
eases [29]. Exercise remains an important tool in reversing the
inflammatory processes and their negative consequences [30,
31].
Physical Activity and Chronic Kidney Disease
The level of physical activity decreases with declining kidney
function [32]. Factors associated with CKD contributing to
exercise intolerance and serving as meaningful barriers to reg-
ular physical activity include anemia, hypertension, and bone
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Fig. 1 Diagram presenting
mechanisms through which
exercise influences beneficial
outcomes in patients with DKD
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and muscle wasting (Table 2) [33]. Patients also listed fear of
injury or aggravating their disease, a lack of guidance from
healthcare professionals, and a lack of local facilities as addi-
tional factors leading to sedentary lifestyle in CKD [10].
Most of the studies addressing exercise in individuals with
CKD were short-term and confirmed the beneficial effects of
exercise on cardiovascular risk factors. For example, a com-
prehensive Cochrane review that included 45 randomized
controlled studies with 1863 participants with CKD who en-
gaged in different types of physical activity for at least 8 weeks
demonstrated that regular exercise has beneficial effects on
physical fitness, walking capacity, blood pressure, and heart
rate, as well as on quality of life [34, 35]. In addition, obser-
vational cohort studies confirmed the beneficial effects of ex-
ercise on cardiovascular disease or mortality [36–38] in pa-
tients with CKD.
Benefits of Physical Activity Across the Spectrum of Kidney
Disease During exercise, as the muscle oxygen requirement
increases, the blood flow to the internal organs, including the
kidneys, is reduced. Renal plasma flow and glomerular filtra-
tion rate decrease in response to increase in exercise intensity.
Therefore, even though physical activity has been shown to
have a positive impact on cardiovascular risk factors, it is
important to understand its effects on renal function at differ-
ent levels of CKD.
Exercise was shown to have beneficial [39, 40] or incon-
clusive [41] effects on the preservation of kidney function in
observational cohort studies. Specifically, in pre-dialysis pa-
tients, most of the interventional studies could show only sta-
bilization of renal function [42–45], whereas in a single inter-
ventional study, a positive effect of exercise on the progres-
sion of CKD was shown [46]. In this particular study, resis-
tance training exercises together with low-protein diet were
able to counterbalance protein catabolism in patients with re-
nal failure, resulting in a significant decrease in inflammatory
markers, improvement in muscle strength, and an improve-
ment of eGFR.
A special group of patients with CKD is those on chronic
hemodialysis. In this group, consistent evidence shows that
aerobic exercise increases physical fitness, muscle strength,
and quality of life [33, 47]. Moreover, in the absence of
RCTs, cohort data show that dialysis patients, who engaged
in more frequent exercise regimens, had a reduced mortality
rate compared with their less active peers [48].
Kidney transplant recipients also benefit from participating
in exercise. Studies have demonstrated improvements in mus-
cle strength, exercise capacity, heart rate variability, and qual-
ity of life when patients engaged in regular aerobic or com-
bined aerobic and resistance exercises [49–51]. However,
these studies could not demonstrate benefits with respect to
renal function, possibly because of eGFR in normal or near-
normal range and a relatively short follow-up.
Physical Activity in Preventing Initiation
and Progression of DKD in Type 1 Diabetes
Individuals with diabetes and proteinuria typically develop
progressive renal failure. Hence, possible beneficial effects
of physical activity on kidney disease initiation and progres-
sion in this population are of great clinical importance.
While animal models investigating the effect of aerobic
training have shown reduced progression of nephropathy in
rats with type 1 diabetes [52], understanding of the effects of
exercise among patients with diabetes from interventional
studies remains limited. In patients with type 2 diabetes, stren-
uous exercise was shown to worsen albuminuria immediately
after the activity [53]. Thirty minutes after exercise, urinary
albumin excretion rate is increased, at least partly influenced
by the increased angiotensin-2 level and enhanced glomerular
membrane permeability. In addition, lactic acid, that is pro-
duced during strenuous exercise, is filtered by the glomeruli,
enters the tubular lumen, and inhibits reabsorption of proteins
at the proximal tubule, such as beta2-microglobulin, thus lead-
ing to tubular proteinuria [54].
Large randomized controlled trials studying the effects of
physical activity on nephropathy in patients with type 1 dia-
betes do not exist. The first available data on exercise effects
on microvascular complications in type 1 diabetes came from
the Pittsburgh study [55]. The study showed that current phys-
ical activity as well as physical activity that the patients un-
dertook during adolescence was inversely associated with the
risk of diabetic nephropathy and neuropathy in men, but not in
women. Unsurprisingly, patients with nephropathy undertook
less physical activity, probably as a consequence of adverse
effects of renal disease. Interestingly, in the FinnDiane cross-
sectional study, even patients withmicroalbuminuria were less
phys ica l ly ac t ive compared wi th pa t i en t s wi th
normoalbuminuria [56].
Prospective data from two large cohorts that evaluated the
effects of physical activity on nephropathy are available. The
first one is the DCCT cohort [57]. Since the study included
newly diagnosed type 1 diabetes patients, the number of renal
events was small and perhaps that was the reason why the
study did not find any association between physical activity
and nephropathy development. Nevertheless, the authors con-
cluded that since they could not detect any harm imposed by
exercise on renal disease, exercise should be encouraged in
management of type 1 diabetes.
The other large set of data comes from our FinnDiane
study that includes patients with type 1 diabetes at various
disease stages. Its primary aim is to identify clinical, bio-
chemical, and genetic factors that predispose to diabetic
nephropathy and other chronic diabetic complications. In
the study that investigated the effect of exercise on diabetic
nephropathy, we included 1424 extensively characterized
patients with diabetes duration of more than 20 years and
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followed their progression in albumin excretion rate or
development of ESRD through a mean follow-up time
6.4 ± 3.1 years [58]. At baseline, the leisure time physical
activity level was assessed using a comprehensive validat-
ed self-report questionnaire. With the help of this question-
naire, 4 components of physical activity were assessed:
total amount, intensity, frequency, and duration of physical
activity. The study was able to demonstrate for the first
time in a prospective setting that physical activity is asso-
ciated with the initiation (development of de novo
microalbuminuria) as well as the progression of diabetic
nephropathy. Moreover, the data showed that it was not
the total amount of physical activity that was important,
but rather its intensity. Namely, the greater the intensity
of exercise, the lower was the risk of occurrence or pro-
gression of diabetic nephropathy. The beneficial associa-
tion of moderate and high intensity physical activity with
the progression of renal disease was unaffected by the di-
abetes duration, age at diabetes onset, sex, or smoking.
However, the strength of the association was attenuated
after controlling for confounding factors such as HbA1c,
BMI, blood pressure, and triacylglycerol [58]. In addition,
albeit the study was longitudinal, it was observational by
design; therefore, the possibility of reverse causality can-
not be completely excluded. Consequently, we cannot ex-
clude the possibility that factors, associated with the ability
to exercise, but not physical activity per se, were associat-
ed with lower risk of adverse renal outcomes.
Of note, recent genetic data from three large case-control
cohorts confirm a causal role of obesity in DKD using a
Mendelian randomization analysis [59]. Therefore, physical
activity could have positive effects on DKD progression also
through its effects on reducing obesity.
Physical Activity Effects on Cardiovascular Events and
Mortality in Type 1 Diabetes From the FinnDiane data, we
were also able to show that frequent and intensive physical
activity reduces cardiovascular events in type 1 diabetes [60•].
From the 2074 patients without prevalent cardiovascular dis-
ease included, aged 38.8 ± 12.4 years, with a diabetes duration
of 21.7 ± 12.4 years, a total of 206 individuals experienced a
cardiovascular event during a 10-year follow-up. We were
able to show that the individuals who participated in low in-
tensity levels of physical activity had a 59% greater relative
risk of incident cardiovascular events compared with those
who practiced high intensity physical activity, even after ad-
justment for sex, diabetes duration, age of diabetes onset, and
the presence of diabetic nephropathy.
Furthermore, our group has recently investigated wheth-
er exercise amount or intensity influences the risk of pre-
mature mortality in patients with type 1 diabetes [61]. We
included 2639 patients, 40.1 ± 12.6 years old, with 23.3 ±
12.8 years of diabetes duration. A total of 270 deaths
occurred over a period of 11.4 ± 3.5 years. The total
amount of self-reported physical activity at baseline was
significantly associated with the mortality at follow-up,
even after adjusting for sex, smoking, diabetes duration,
age of diabetes onset, the presence of diabetic nephropathy,
HbA1c, triglycerides, systolic blood pressure, and BMI. In
addition, the relative risk of premature mortality rate was
almost doubled in face of low versus moderate/high level
of either of exercise components, including intensity, du-
ration or frequency, even after adjustment for sex, diabetes
duration, age of diabetes onset, smoking, and nephropathy
presence [61]. Patients with CKD, defined in this study as
eGFR below 60 ml/min/1.73m2, experienced similar ben-
eficial effects of physical activity on mortality, although
when adjusted for the confounders specifically the total
amount of leisure time physical activity and exercise fre-
quency were independently associated with all-cause mor-
tality [61]. Altogether, our results suggest that exercise, in
particular a high frequency and high intensity exercise,
may reduce the risk of diabetic kidney disease, cardiovas-
cular disease, and mortality in type 1 diabetes.
Contraindications to Physical Activity
While engaging in physical activity may exert multiple bene-
ficial effects on well-being over time, sedentary patients with
diabetes should be educated on potential adverse events asso-
ciated with the initiation of an exercise program. For example,
the risk of hypoglycemia may be increased during and after
exercise. Therefore, in preparation for exercise, individuals
should be aware of their blood glucose concentrations, have
their blood glucose monitoring equipment, and snacks in
cases of hypoglycemia available. Aerobic exercise should be
started only after the glucose concentration is above 7 mmol/l
(126 mg/dl); however, anaerobic exercise can be started after
glucose levels are above 5 mmol/l (90 mg/dl). If the glucose
concentration is above 15 mmol/l (270 mg/dl), exercise could
promote further hyperglycemia, especially in case of
ketonemia [62•].
In addition, in individuals with longstanding diabetes and
high HbA1c, vigorous exercise or activities involving heavy
weight lifting or competitive endurance events are contraindi-
cated. It is particularly true if the individual is suffering from
proliferative diabetic retinopathy or severe non-proliferative
diabetic retinopathy because of the risk of triggering vitreous
hemorrhage or retinal detachment [1]. In addition, patients
with cardiac autonomic neuropathy and renal failure should
undergo clinical evaluation before intensifying exercise regi-
men [62•]. Patients on beta-blockers should be informed that
adrenergic symptoms of hypoglycemia may be blunted during
exercise [63]. Also, in patients with neuropathy, careful feet
inspection is needed to prevent foot ulceration.
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Conclusions
In individuals with type 1 diabetes at risk of DKD or
with established DKD, regular moderate-to-vigorous
physical activity is associated with reduced incidence
and progression of kidney disease, as well as reduced
risk of cardiovascular events and mortality. Since struc-
tured physical activity has great potential to enhance
health and quality of life at all stages of chronic kidney
disease [33], exercise advice and physical activity as-
sessment should become a routine integral part of the
patient-centered treatment strategy also in type 1
diabetes.
Even though guidelines regarding the optimal type,
frequency, intensity, and duration of physical activity
for preventing DKD or DKD progression have yet to
be formalized, it seems reasonable, in patients without
contraindications, to follow the general advice of at
least 150 min of moderate-to-vigorous aerobic exercise
per week, combined with resistance exercises two to
three times per week [1]. Promoting exercise in individ-
uals with type 1 diabetes needs awareness and acknowl-
edgment of all the potential barriers to physical activity,
with special focus on improving patient education and
autonomy around exercise self-management.
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